ABSTRACT
Background:Usage of cosmetic products has been increased significantly in last few decades. Their usage has increased beyond the purpose of beautification. The definition of cosmetic product varies widely amidst different countries. Increased concern of physical appearance in population throughout the globe has been taken as an advantage by the cosmetic industries. Increased usage of different personal care products for prolonged period of time leads to exposure of the human body to wide variety of chemicals which maylead to adverse effects. Heavy metals have been found in certain cosmetic products which not only lead to dermatological but systemic adverse effects too. Further to this, pharmacologically active agents have been found in anti aging products. These cosmeceutical agents may possess chemical agents which are toxic to human body. Western countries have laid certain regulatory guidelines for manufacturing, labelling and marketing of cosmetic products. Cosmetovigilance ensures appropriate and safe use of cosmetic products. In India, Drugs and Cosmetic Act governs the regulations for the cosmetic products. Need of formal adverse event reporting system as well as strict regulatory guidelines for cosmetic products are required to curtail the adverse health outcomes due to cosmetic products.
ABSTRACT
Os produtos cosméticos e farmacêuticos contendo componentes de origem natural têm aumentado significativamente nos últimos anos. Com o objetivo de utilizar esses componentes como conservante em formulações cosméticas, determinou-se a atividade antimicrobiana do extrato bruto de folhas de Rubus rosaefolius Sm. e suas frações. Aquele de melhor desempenho foi avaliado quanto à toxicidade in vitro e seu comportamento em formulações cosméticas (creme, gel e xampu), relacionado à estabilidade, eficácia do sistema conservante e compatibilidade epidérmica. A atividade antimicrobiana foi determinada pelo método de microdiluição e a concentração de 0,2% (p/v) do extrato bruto apresentou melhor desempenho. O teste de toxicidade do extrato bruto foi realizado por meio do método colorimétrico Cell Titer 96®, MTS, em cultura de queratinócitos humanos, constatando-se índice de citotoxicidade (IC50) de 1,0 mg/mL. As formulações cosméticas contendo o extrato foram analisadas quanto à estabilidade e as de melhor desempenho foram submetidas ao teste de eficácia do sistema conservante, de acordo com os procedimentos descritos na CTFA. O sistema conservante mostrou-se efetivo frente à Escherichia coli IAL 2393 (ATCC 10536), a Pseudomonas aeruginosa IAL 1874 (ATCC 9027), ao Staphylococcus aureus IAL 1875 (ATCC 6548), a Burkholderia cepacia IAL 1834 ATCC (17759) e a Candida albicans IAL 1611 (ATCC 10231). Avaliouse a compatibilidade epidérmica das formulações em equivalentes dermo-epidérmicos, sistema tridimensional cultivados na superfície ar-líquido. Os resultados mostraram que houve diferenças na compatibilidade epidérmica dependendo das características dos componentes das formulações. Concluiu-se que o extrato bruto de folhas de Rubus rosaefolius Sm. a 0,2% (p/v) pode ser utilizado como candidato a conservante em formulações cosméticas, sendo estável e apresentar compatibilidade epidérmica.
Cosmetic and pharmaceuticals products contained natural compounds have increased in the last few years. To verify the use of these compounds as preservative in formulations, the antimicrobial activity from the raw extract of the Rubus rosaefolius Sm. leaves and its fractions was determined. The toxicity in vitro and the behavior in cosmetic formulations (gel, emulsion and shampoo), regarding to the stability, effectiveness of the preservative system, and epidermal compatibility were evaluated in the extract, which had the best preservative action. The antimicrobial activity was determined by the micro dilution method, and the 0.2% concentration (w/v) of the raw extract had the best performance. The toxicity of the extract was analyzed by Cell Titer 96® colorimetric; MTS method in human keratinocytes culture, and the index of cytotoxicity (IC 50) found was 1.0 mg/mL. The cosmetic formulations with the raw extract were analyzed regarding to the stability and the best formulations were submitted to preservative challenge test, according to CTFA procedures. The preservative system was effective against Escherichia coli IAL 2393 (ATCC 10536), Pseudomonas aeruginosa IAL 1874 (ATCC 9027), Staphylococcus aureus IAL 1875 (ATCC 6548), Burkholderia cepacia IAL 1834 ATCC (17759), and Candida albicans IAL 1611 (ATCC 10231). The epidermal compatibility of the formulations was verified by skin (dermo-epidermal) equivalent, three-dimensional system, cultivated in the air-liquid surface. The results showed there were differences in the epidermal compatibility depended on the ingredient of formulation. In conclusion, the raw extract from the Rubus rosaefolius Sm leaves 0.2% (w/v) can be used as preservative candidate in the cosmetic formulations analyzed due to stability and it presented epidermal compatibility.